Johnny Ndoni Mahlangu

机构：National Health Laboratory Service, University of the Witwatersrand, Johannesburg Hospital · ORCID：0000-0001-5781-7669

发表论文 346 篇 · 总被引 13970 次 · h-index 47

代表论文

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B (2025 · New England Journal of Medicine · 被引 63)
Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial (2025 · Blood · 被引 38)
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025 (2025 · Haemophilia · 被引 13)
Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial (2025 · Blood · 被引 12)
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors (2026 · New England Journal of Medicine · 被引 9)
FRONTIER1 multiple ascending dose extension: a safety, tolerability, pharmacokinetics, and pharmacodynamics study of Mim8 in people with hemophilia A (2025 · Research and Practice in Thrombosis and Haemostasis · 被引 8)